MERIT CRO, a leading provider of endpoint services for clinical trials, has established a venture capital platform, Mianus Capital, to invest in early-stage healthcare companies. This venture capital platform allows MERIT to leverage its deep domain expertise and network within the healthcare ecosystem to identify promising startups and mitigate investment risk. MERIT aims to share these promising deals with other VCs to accelerate clinical progress and attract more investment for early-stage companies. By collaborating with MERIT, VCs gain access to specialized knowledge and a network of promising startups, enabling them to invest early and potentially reap substantial returns. This strategic collaboration aims to create a win-win scenario for all parties involved, fostering innovation, accelerating clinical trials, and ultimately driving greater returns for investors.